SLL

Oncology

10 drugs in development·6 companies·2 clinical trials

Drug Pipeline by Phase

Approved(2)

Drug	Company
brukinsa	BeOne Medicines Ltd. (ONC)
venetoclax	DR REDDYS LABORATORIES LTD (RDY)

Phase 3(6)

Drug	Company
bexobrutideg	Nurix Therapeutics, Inc. (NRIX)
btk inhibitor	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
btk inhibitor	CHINA PHARMA HOLDINGS, INC. (CPHI)
lisaftoclax	CHINA PHARMA HOLDINGS, INC. (CPHI)
lisaftoclax +btk inhibitor	CHINA PHARMA HOLDINGS, INC. (CPHI)
lisaftoclax +btk inhibitor	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)

Phase 2(1)

Drug	Company
bruton's tyrosine kinase inhibitor	GH Research PLC (GHRS)

Phase 1(1)

Drug	Company
lisaftoclax	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)

BioSniper tracks 10 drugs in development for SLL across 6 companies.

There are 2 clinical trials targeting SLL tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.